Eliot Newton-Mann, C. Finney, T. Purves-Tyson, A. Gogos
{"title":"雌激素受体:作用机制及其与精神分裂症的相关性","authors":"Eliot Newton-Mann, C. Finney, T. Purves-Tyson, A. Gogos","doi":"10.2174/1573400513666170414102145","DOIUrl":null,"url":null,"abstract":"Sex differences are observed in schizophrenia, with women exhibiting an overall better disease outcome leading to the estrogen hypothesis of schizophrenia that postulates a protective role of estrogen against the development and severity of the disorder. Estrogen (17β-estradiol) is a sex steroid hormone; its primary mechanism of action is via binding to estrogen receptors and initiating gene expression. While there has been significant attention placed on the impact of estrogen in schizophrenia, less is known about the importance of the estrogen receptors in schizophrenia. This narrative review describes estrogen receptor subtypes including the distribution of these receptors in the brain, with a particular focus on the two main subtypes: estrogen receptor-alpha (ERα, or ESR1) and -beta (ERβ, or ESR2). This review highlights the research on estrogen receptors in schizophrenia. Given that this literature is limited, particularly with respect to ERβ, we argue for a more considered effort of future studies to further understand the role of estrogen and its receptors in schizophrenia and to further elucidate the mechanisms underlying the therapeutic effect of estrogen and estrogen receptor modulation in schizophrenia. Such an effort may lead to more targeted novel therapeutic approaches as well as enhance our understanding of the sex differences observed in schizophrenia and other psychiatric disorders.","PeriodicalId":51774,"journal":{"name":"Current Psychiatry Reviews","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":"{\"title\":\"Estrogen Receptors: Mechanism of Action and Relevance to Schizophrenia\",\"authors\":\"Eliot Newton-Mann, C. Finney, T. Purves-Tyson, A. Gogos\",\"doi\":\"10.2174/1573400513666170414102145\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Sex differences are observed in schizophrenia, with women exhibiting an overall better disease outcome leading to the estrogen hypothesis of schizophrenia that postulates a protective role of estrogen against the development and severity of the disorder. Estrogen (17β-estradiol) is a sex steroid hormone; its primary mechanism of action is via binding to estrogen receptors and initiating gene expression. While there has been significant attention placed on the impact of estrogen in schizophrenia, less is known about the importance of the estrogen receptors in schizophrenia. This narrative review describes estrogen receptor subtypes including the distribution of these receptors in the brain, with a particular focus on the two main subtypes: estrogen receptor-alpha (ERα, or ESR1) and -beta (ERβ, or ESR2). This review highlights the research on estrogen receptors in schizophrenia. Given that this literature is limited, particularly with respect to ERβ, we argue for a more considered effort of future studies to further understand the role of estrogen and its receptors in schizophrenia and to further elucidate the mechanisms underlying the therapeutic effect of estrogen and estrogen receptor modulation in schizophrenia. Such an effort may lead to more targeted novel therapeutic approaches as well as enhance our understanding of the sex differences observed in schizophrenia and other psychiatric disorders.\",\"PeriodicalId\":51774,\"journal\":{\"name\":\"Current Psychiatry Reviews\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Psychiatry Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1573400513666170414102145\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Psychiatry Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573400513666170414102145","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Estrogen Receptors: Mechanism of Action and Relevance to Schizophrenia
Sex differences are observed in schizophrenia, with women exhibiting an overall better disease outcome leading to the estrogen hypothesis of schizophrenia that postulates a protective role of estrogen against the development and severity of the disorder. Estrogen (17β-estradiol) is a sex steroid hormone; its primary mechanism of action is via binding to estrogen receptors and initiating gene expression. While there has been significant attention placed on the impact of estrogen in schizophrenia, less is known about the importance of the estrogen receptors in schizophrenia. This narrative review describes estrogen receptor subtypes including the distribution of these receptors in the brain, with a particular focus on the two main subtypes: estrogen receptor-alpha (ERα, or ESR1) and -beta (ERβ, or ESR2). This review highlights the research on estrogen receptors in schizophrenia. Given that this literature is limited, particularly with respect to ERβ, we argue for a more considered effort of future studies to further understand the role of estrogen and its receptors in schizophrenia and to further elucidate the mechanisms underlying the therapeutic effect of estrogen and estrogen receptor modulation in schizophrenia. Such an effort may lead to more targeted novel therapeutic approaches as well as enhance our understanding of the sex differences observed in schizophrenia and other psychiatric disorders.
期刊介绍:
Current Psychiatry Reviews publishes frontier reviews on all the latest advances on clinical psychiatry and its related areas e.g. pharmacology, epidemiology, clinical care, and therapy. The journal’s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all clinicians, psychiatrists and researchers in psychiatry.